Literature DB >> 29384096

[Regulation of the NLRP3 inflammasome].

Marine Groslambert1, Bénédicte F Py1.   

Abstract

The innate immunity constitutes an efficient barrier by rapidly detecting pathogens and tissue damages through pattern recognition receptors including NLRP3. Moreover, inappropriate NLRP3 activation causes deleterious inflammation and contributes to various conditions including atherosclerosis, diabetes, gout and Alzheimer's diseases. NLRP3 assembles a multimeric inflammasome complex serving as an activation platform for caspase-1 that controls processing and release of cytosolic inflammatory factors and cytokines including IL-1β Inflammasome assembly is tightly controlled and requires coordinated NLRP3 priming, through cytokine or other pattern recognition receptors, followed by activation by cellular stress. Here, we describe recent advances in the understanding of the signalling pathways supporting the priming and activation of NLRP3, with a special focus on the key role of post-translational modifications of NLRP3, including phosphorylation and ubiquitination, in inflammasome regulation.
© 2018 médecine/sciences – Inserm.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29384096     DOI: 10.1051/medsci/20183401013

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  3 in total

1.  Knocking down ETS Proto-oncogene 1 (ETS1) alleviates the pyroptosis of renal tubular epithelial cells in patients with acute kidney injury by regulating the NLR family pyrin domain containing 3 (NLRP3) transcription.

Authors:  Chenxia Juan; Ye Zhu; Yan Chen; Yan Mao; Yan Zhou; Weiwei Zhu; Xufang Wang; Qian Wang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 2.  Role of pyroptosis in spinal cord injury and its therapeutic implications.

Authors:  Abdullah Al Mamun; Yanqing Wu; Ilma Monalisa; Chang Jia; Kailiang Zhou; Fahad Munir; Jian Xiao
Journal:  J Adv Res       Date:  2020-08-18       Impact factor: 10.479

Review 3.  The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?

Authors:  Brendan Le Daré; Pierre-Jean Ferron; Thomas Gicquel
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.